biote Corp.
BTMDNasdaq
$2.43
↑ +2.1%Jul 17 close · end-of-day
Price
1Y↓ -40.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$87.5M
Enterprise Value
$182.8M
P/E
5.7
P/S
0.5
P/B
—
EV/EBITDA
5.6
PEG
—
FCF Yield
33.0%
Dividend Yield
—
Revenue (TTM)
$188.2M
Net Income (TTM)
$15.6M
Free Cash Flow (TTM)
$28.9M
Gross Margin
—
Operating Margin
15.4%
Net Margin
8.3%
ROE
-27.8%
ROIC
58.1%
Debt / Equity
-1.8
Net Cash
-$95.4M
Return 1Y
-41.7%
Company profile
Haymaker Acquisition Corp. III does not have any significant operations. The company was incorporated in 2020 and is based in New York, New York.
- CEO
- Terry S. Weber
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Headquarters
- Texas
- Website
- biote.com
Earnings
BTMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$44.9M↓ -8.3%
Diluted EPS$0.06↓ -83.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $139.4M | $165.0M | $185.4M | $197.2M | $192.2M |
| Gross profit | — | — | — | — | — |
| Operating income | $34.6M | -$60.7M | $28.7M | $31.6M | $35.6M |
| Net income | $11.1M | -$969,000.00 | $3.3M | $3.2M | $27.0M |
| Diluted EPS | — | -$0.12 | $0.13 | $0.09 | $0.74 |
| Operating cash flow | $33.7M | -$9.2M | $26.9M | $45.2M | $35.2M |
| Free cash flow | $32.3M | -$9.5M | $26.5M | $38.8M | $30.2M |
| Gross margin | — | — | — | — | — |
| Operating margin | 24.8% | -36.8% | 15.5% | 16.0% | 18.5% |
| Net margin | 8.0% | -0.6% | 1.8% | 1.6% | 14.1% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $49.2M | $51.4M | $49.8M | $49.0M | $48.9M | $48.0M | $46.4M | $44.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $6.2M | $12.2M | $2.8M | $9.7M | $10.8M | $8.3M | $6.8M | $3.2M |
| Net income | -$7.1M | $10.7M | $3.7M | $13.7M | $3.2M | $8.2M | $2.0M | $2.3M |
| Diluted EPS | -$0.21 | $0.33 | $0.09 | $0.37 | $0.10 | $0.22 | $0.05 | $0.06 |
| Operating cash flow | $9.9M | $15.6M | $12.4M | $6.5M | $7.1M | $14.1M | $7.6M | $3.9M |
| Free cash flow | $7.4M | $14.0M | $10.7M | $4.8M | $5.3M | $13.6M | $6.5M | $3.5M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 12.7% | 23.7% | 5.6% | 19.8% | 22.0% | 17.2% | 14.7% | 7.0% |
| Net margin | -14.4% | 20.8% | 7.4% | 28.0% | 6.5% | 17.1% | 4.2% | 5.1% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-12 | MORRIS DEBRA L | Option exercise | 21,407 | — | — | filing |
Latest 1 transaction.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.